Andy Kim

574 total citations · 1 hit paper
25 papers, 242 citations indexed

About

Andy Kim is a scholar working on Infectious Diseases, Neurology and Surgery. According to data from OpenAlex, Andy Kim has authored 25 papers receiving a total of 242 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 5 papers in Neurology and 4 papers in Surgery. Recurrent topics in Andy Kim's work include SARS-CoV-2 and COVID-19 Research (6 papers), COVID-19 Clinical Research Studies (6 papers) and Long-Term Effects of COVID-19 (4 papers). Andy Kim is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), COVID-19 Clinical Research Studies (6 papers) and Long-Term Effects of COVID-19 (4 papers). Andy Kim collaborates with scholars based in United States, Canada and Botswana. Andy Kim's co-authors include Ann E. Woolley, Lindsey R. Baden, Scott Dryden‐Peterson, Arthur Y. Kim, Ellen C. Caniglia, Rajesh T. Gandhi, Rajesh Patel, Inga T. Lennes, John D. Walters and Monica Prasad Gibson and has published in prestigious journals such as Annals of Internal Medicine, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Andy Kim

22 papers receiving 237 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System

2022 107 citations Scott Dryden‐Peterson, Andy Kim et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andy Kim United States	8	118	65	41	30	22	25	242
Yasutaka Fukui Japan	10	193 1.6×	45 0.7×	39 1.0×	16 0.5×	37 1.7×	24	322
Rakesh D. Mistry United States	9	54 0.5×	50 0.8×	12 0.3×	34 1.1×	11 0.5×	19	199
Samuel B. Polak Netherlands	4	213 1.8×	133 2.0×	29 0.7×	20 0.7×	30 1.4×	5	332
Salah Eddine Oussama Kacimi Algeria	7	108 0.9×	61 0.9×	50 1.2×	25 0.8×	54 2.5×	18	280
Uddalak Chakraborty India	9	150 1.3×	143 2.2×	42 1.0×	24 0.8×	20 0.9×	59	319
Xiaoshuang Li China	7	183 1.6×	32 0.5×	11 0.3×	11 0.4×	17 0.8×	14	365
Ankita Pandey India	8	126 1.1×	58 0.9×	35 0.9×	14 0.5×	47 2.1×	24	269
Preethi William United States	4	98 0.8×	65 1.0×	24 0.6×	19 0.6×	12 0.5×	9	169
Abdallah Almaghraby Egypt	7	120 1.0×	42 0.6×	55 1.3×	64 2.1×	31 1.4×	76	313
Hardik Dineshbhai Desai India	8	59 0.5×	41 0.6×	51 1.2×	35 1.2×	11 0.5×	52	200

Countries citing papers authored by Andy Kim

Since Specialization

Citations

This map shows the geographic impact of Andy Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Kim more than expected).

Fields of papers citing papers by Andy Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Kim. The network helps show where Andy Kim may publish in the future.

Co-authorship network of co-authors of Andy Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Andy Kim. A scholar is included among the top collaborators of Andy Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andy Kim. Andy Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dryden‐Peterson, Scott, Andy Kim, Ellen C. Caniglia, et al.. (2025). Severe outcomes of COVID-19 among adults with increased risk conditions: A population-based observational study. PLoS ONE. 20(2). e0316529–e0316529. 1 indexed citations

Choe, Goeun, Jongdarm Yi, Andy Kim, et al.. (2024). ROS-scavenging ultrasonicated graphene oxide/alginate microgels for mesenchymal stem cell delivery and hindlimb ischemia treatment. Materials Today Bio. 29. 101289–101289. 3 indexed citations

Grippin, Adam, Andy Kim, Ansel P. Nalin, et al.. (2024). Osteoradionecrosis in Pediatric Patients Treated with Proton Therapy for Head and Neck Malignancies. International Journal of Radiation Oncology*Biology*Physics. 122(1). 159–163.

Paik, Jisun, et al.. (2024). Kinetics of the inhibition and recovery of spermatogenesis induced by treatment with WIN 18,446, a male contraceptive, in mice. Andrology. 13(7). 1913–1918.

Kakoullis, Loukas, Andy Kim, Bridget Yates, et al.. (2023). 2707. Complications of Babesiosis in Immunocompromised and Asplenic/Hyposplenic Patients. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations

Paik, Jisun, et al.. (2023). Return to fertility, toxicology, and transgenerational impact of treatment with WIN 18,446, a potential male contraceptive, in mice. Contraception. 129. 110306–110306. 3 indexed citations

Woolley, Ann E., Scott Dryden‐Peterson, Andy Kim, et al.. (2022). At-home Testing and Risk Factors for Acquisition of SARS-CoV-2 Infection in a Major US Metropolitan Area. Open Forum Infectious Diseases. 9(11). ofac505–ofac505. 1 indexed citations

Weber, Brittany, Daniel Huck, Andy Kim, et al.. (2022). Prior SARS‐CoV‐2 Infection Is Associated With Coronary Vasomotor Dysfunction as Assessed by Coronary Flow Reserve From Cardiac Positron Emission Tomography. Journal of the American Heart Association. 11(20). e025844–e025844. 8 indexed citations

Kim, Andy, Margaret M. McCarthy, Rajesh Patel, et al.. (2022). Feasibility and lessons learned on remote trial implementation from TestBoston, a fully remote, longitudinal, large-scale COVID-19 surveillance study. PLoS ONE. 17(6). e0269127–e0269127. 8 indexed citations

10.

Dryden‐Peterson, Scott, Andy Kim, Jennifer Johnson, et al.. (2022). Bebtelovimab for High-Risk Outpatients With Early COVID-19 in a Large US Health System. Open Forum Infectious Diseases. 9(11). 9 indexed citations

11.

Kim, Andy, et al.. (2022). Serum Sodium, Patient Symptoms, and Clinical Outcomes in Hospitalized Patients with COVID-19. Journal of Primary Care & Community Health. 13. 4257687509–4257687509. 2 indexed citations

12.

Siddiqi, Hasan K., Brittany Weber, Andy Kim, et al.. (2021). STATIN USE AND OUTCOMES IN HOSPITALIZED PATIENTS WITH SARS-COV-2 INFECTION. Journal of the American College of Cardiology. 77(18). 3091–3091. 1 indexed citations

13.

Weber, Brittany, Hasan K. Siddiqi, Guohai Zhou, et al.. (2021). RELATIONSHIPS BETWEEN MYOCARDIAL INJURY, INDEX HOSPITALIZATION CHARACTERISTICS, AND LONGER-TERM OUTCOMES IN SARS-COV-2 INFECTION. Journal of the American College of Cardiology. 77(18). 3025–3025. 1 indexed citations

14.

Kim, Andy, et al.. (2020). Antibiotic prophylaxis for implant placement: a systematic review of effects on reduction of implant failure. BDJ. 228(12). 943–951. 33 indexed citations

15.

Kim, Andy, et al.. (2019). A novel dried blood spots analysis combined with on-spot reaction for determination of trimethylamine N-oxide and its related compounds. Talanta. 210. 120639–120639. 5 indexed citations

16.

Kim, Andy, et al.. (2019). 976: ENTERAL METHADONE USE IN CRITICALLY ILL PATIENTS TO DECREASE CONTINUOUS OPIOID INFUSION REQUIREMENTS. Critical Care Medicine. 48(1). 467–467.

17.

Ong, Charlene, Meghan R. Hutch, Megan E. Barra, et al.. (2018). Effects of Osmotic Therapy on Pupil Reactivity: Quantification Using Pupillometry in Critically Ill Neurologic Patients. Neurocritical Care. 30(2). 307–315. 31 indexed citations

18.

Czarna, Anna, Fumihiro Sanada, Alex Matsuda, et al.. (2017). Single-cell analysis of the fate of c-kit-positive bone marrow cells. npj Regenerative Medicine. 2(1). 27–27. 13 indexed citations

19.

Kim, Andy, et al.. (2016). 1803: COMBINATION ANTIBIOTIC THERAPY FOR THE TREATMENT OF SEVERE, NECROTIZING MRSA PNEUMONIA. Critical Care Medicine. 44(12). 526–526. 1 indexed citations

20.

Kim, Andy, Doru T Alexandrescu, Constantin A Dasanu, et al.. (2014). Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy. Journal of Translational Medicine. 12(1). 127–127. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact